3.20.2 html 179 279 1 false 59 0 false 8 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.veracyte.com/20200930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.veracyte.com/20200930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.veracyte.com/20200930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://www.veracyte.com/20200930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.veracyte.com/20200930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) Sheet http://www.veracyte.com/20200930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited-parentheticals Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) Statements 6 false false R7.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.veracyte.com/20200930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies Sheet http://www.veracyte.com/20200930/role/statement-note-1-organization-description-of-business-and-summary-of-significant-accounting-policies Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Net Loss Per Common Share Sheet http://www.veracyte.com/20200930/role/statement-note-2-net-loss-per-common-share Note 2 - Net Loss Per Common Share Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Accrued Liabilities Sheet http://www.veracyte.com/20200930/role/statement-note-3-accrued-liabilities Note 3 - Accrued Liabilities Notes 10 false false R11.htm 010 - Disclosure - Note 4 - Business Combination Sheet http://www.veracyte.com/20200930/role/statement-note-4-business-combination- Note 4 - Business Combination Notes 11 false false R12.htm 011 - Disclosure - Note 5 - Fair Value Measurements Sheet http://www.veracyte.com/20200930/role/statement-note-5-fair-value-measurements Note 5 - Fair Value Measurements Notes 12 false false R13.htm 012 - Disclosure - Note 6 - Commitments and Contingencies Sheet http://www.veracyte.com/20200930/role/statement-note-6-commitments-and-contingencies Note 6 - Commitments and Contingencies Notes 13 false false R14.htm 013 - Disclosure - Note 7 - Debt Sheet http://www.veracyte.com/20200930/role/statement-note-7-debt Note 7 - Debt Notes 14 false false R15.htm 014 - Disclosure - Note 8 - Stockholders' Equity Sheet http://www.veracyte.com/20200930/role/statement-note-8-stockholders-equity Note 8 - Stockholders' Equity Notes 15 false false R16.htm 015 - Disclosure - Note 9 - Thyroid Cytopathology Partners Sheet http://www.veracyte.com/20200930/role/statement-note-9-thyroid-cytopathology-partners Note 9 - Thyroid Cytopathology Partners Notes 16 false false R17.htm 016 - Disclosure - Note 10 - Income Taxes Sheet http://www.veracyte.com/20200930/role/statement-note-10-income-taxes Note 10 - Income Taxes Notes 17 false false R18.htm 017 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.veracyte.com/20200930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.veracyte.com/20200930/role/statement-note-1-organization-description-of-business-and-summary-of-significant-accounting-policies 18 false false R19.htm 018 - Disclosure - Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies (Tables) Sheet http://www.veracyte.com/20200930/role/statement-note-1-organization-description-of-business-and-summary-of-significant-accounting-policies-tables Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies (Tables) Tables http://www.veracyte.com/20200930/role/statement-note-1-organization-description-of-business-and-summary-of-significant-accounting-policies 19 false false R20.htm 019 - Disclosure - Note 2 - Net Loss Per Common Share (Tables) Sheet http://www.veracyte.com/20200930/role/statement-note-2-net-loss-per-common-share-tables Note 2 - Net Loss Per Common Share (Tables) Tables http://www.veracyte.com/20200930/role/statement-note-2-net-loss-per-common-share 20 false false R21.htm 020 - Disclosure - Note 3 - Accrued Liabilities (Tables) Sheet http://www.veracyte.com/20200930/role/statement-note-3-accrued-liabilities-tables Note 3 - Accrued Liabilities (Tables) Tables http://www.veracyte.com/20200930/role/statement-note-3-accrued-liabilities 21 false false R22.htm 021 - Disclosure - Note 4 - Business Combination (Tables) Sheet http://www.veracyte.com/20200930/role/statement-note-4-business-combination-tables Note 4 - Business Combination (Tables) Tables http://www.veracyte.com/20200930/role/statement-note-4-business-combination- 22 false false R23.htm 022 - Disclosure - Note 5 - Fair Value Measurements (Tables) Sheet http://www.veracyte.com/20200930/role/statement-note-5-fair-value-measurements-tables Note 5 - Fair Value Measurements (Tables) Tables http://www.veracyte.com/20200930/role/statement-note-5-fair-value-measurements 23 false false R24.htm 023 - Disclosure - Note 6 - Commitments and Contingencies (Tables) Sheet http://www.veracyte.com/20200930/role/statement-note-6-commitments-and-contingencies-tables Note 6 - Commitments and Contingencies (Tables) Tables http://www.veracyte.com/20200930/role/statement-note-6-commitments-and-contingencies 24 false false R25.htm 024 - Disclosure - Note 7 - Debt (Tables) Sheet http://www.veracyte.com/20200930/role/statement-note-7-debt-tables Note 7 - Debt (Tables) Tables http://www.veracyte.com/20200930/role/statement-note-7-debt 25 false false R26.htm 025 - Disclosure - Note 8 - Stockholders' Equity (Tables) Sheet http://www.veracyte.com/20200930/role/statement-note-8-stockholders-equity-tables Note 8 - Stockholders' Equity (Tables) Tables http://www.veracyte.com/20200930/role/statement-note-8-stockholders-equity 26 false false R27.htm 026 - Disclosure - Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies (Details Textual) Sheet http://www.veracyte.com/20200930/role/statement-note-1-organization-description-of-business-and-summary-of-significant-accounting-policies-details-textual Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies (Details Textual) Details http://www.veracyte.com/20200930/role/statement-note-1-organization-description-of-business-and-summary-of-significant-accounting-policies-tables 27 false false R28.htm 027 - Disclosure - Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies - Schedule of Third-party Payers as a Percentage of Total (Details) Sheet http://www.veracyte.com/20200930/role/statement-note-1-organization-description-of-business-and-summary-of-significant-accounting-policies-schedule-of-thirdparty-payers-as-a-percentage-of-total-details Note 1 - Organization, Description of Business and Summary of Significant Accounting Policies - Schedule of Third-party Payers as a Percentage of Total (Details) Details 28 false false R29.htm 028 - Disclosure - Note 2 - Net Loss Per Common Share - Anti-dilutive Common Stock Equivalents Excluded from Diluted Net Loss Per Common Share (Details) Sheet http://www.veracyte.com/20200930/role/statement-note-2-net-loss-per-common-share-antidilutive-common-stock-equivalents-excluded-from-diluted-net-loss-per-common-share-details Note 2 - Net Loss Per Common Share - Anti-dilutive Common Stock Equivalents Excluded from Diluted Net Loss Per Common Share (Details) Details 29 false false R30.htm 029 - Disclosure - Note 3 - Accrued Liabilities - Accrued Liabilities (Details) Sheet http://www.veracyte.com/20200930/role/statement-note-3-accrued-liabilities-accrued-liabilities-details Note 3 - Accrued Liabilities - Accrued Liabilities (Details) Details 30 false false R31.htm 030 - Disclosure - Note 4 - Business Combination (Details Textual) Sheet http://www.veracyte.com/20200930/role/statement-note-4-business-combination-details-textual Note 4 - Business Combination (Details Textual) Details http://www.veracyte.com/20200930/role/statement-note-4-business-combination-tables 31 false false R32.htm 031 - Disclosure - Note 4 - Business Combination - Fair Values of Assets Acquired and Liabilities Assumed (Details) Sheet http://www.veracyte.com/20200930/role/statement-note-4-business-combination-fair-values-of-assets-acquired-and-liabilities-assumed-details Note 4 - Business Combination - Fair Values of Assets Acquired and Liabilities Assumed (Details) Details 32 false false R33.htm 032 - Disclosure - Note 4 - Business Combination - Estimated Useful Life of Acquisition-related Intangibles (Details) Sheet http://www.veracyte.com/20200930/role/statement-note-4-business-combination-estimated-useful-life-of-acquisitionrelated-intangibles-details Note 4 - Business Combination - Estimated Useful Life of Acquisition-related Intangibles (Details) Details 33 false false R34.htm 033 - Disclosure - Note 5 - Fair Value Measurements (Details Textual) Sheet http://www.veracyte.com/20200930/role/statement-note-5-fair-value-measurements-details-textual Note 5 - Fair Value Measurements (Details Textual) Details http://www.veracyte.com/20200930/role/statement-note-5-fair-value-measurements-tables 34 false false R35.htm 034 - Disclosure - Note 5 - Fair Value Measurements - Fair Value Measurement Input (Details) Sheet http://www.veracyte.com/20200930/role/statement-note-5-fair-value-measurements-fair-value-measurement-input-details Note 5 - Fair Value Measurements - Fair Value Measurement Input (Details) Details 35 false false R36.htm 035 - Disclosure - Note 6 - Commitments and Contingencies (Details Textual) Sheet http://www.veracyte.com/20200930/role/statement-note-6-commitments-and-contingencies-details-textual Note 6 - Commitments and Contingencies (Details Textual) Details http://www.veracyte.com/20200930/role/statement-note-6-commitments-and-contingencies-tables 36 false false R37.htm 036 - Disclosure - Note 6 - Commitments and Contingencies - Future Minimum Lease Payments (Details) Sheet http://www.veracyte.com/20200930/role/statement-note-6-commitments-and-contingencies-future-minimum-lease-payments-details Note 6 - Commitments and Contingencies - Future Minimum Lease Payments (Details) Details 37 false false R38.htm 037 - Disclosure - Note 7 - Debt (Details Textual) Sheet http://www.veracyte.com/20200930/role/statement-note-7-debt-details-textual Note 7 - Debt (Details Textual) Details http://www.veracyte.com/20200930/role/statement-note-7-debt-tables 38 false false R39.htm 038 - Disclosure - Note 7 - Debt - Net Debt Obligation for Borrowings (Details) Sheet http://www.veracyte.com/20200930/role/statement-note-7-debt-net-debt-obligation-for-borrowings-details Note 7 - Debt - Net Debt Obligation for Borrowings (Details) Details 39 false false R40.htm 039 - Disclosure - Note 8 - Stockholders' Equity - Reserved Shares of Common Stock for Issuance (Details) Sheet http://www.veracyte.com/20200930/role/statement-note-8-stockholders-equity-reserved-shares-of-common-stock-for-issuance-details Note 8 - Stockholders' Equity - Reserved Shares of Common Stock for Issuance (Details) Details 40 false false R41.htm 040 - Disclosure - Note 9 - Thyroid Cytopathology Partners (Details Textual) Sheet http://www.veracyte.com/20200930/role/statement-note-9-thyroid-cytopathology-partners-details-textual Note 9 - Thyroid Cytopathology Partners (Details Textual) Details http://www.veracyte.com/20200930/role/statement-note-9-thyroid-cytopathology-partners 41 false false R42.htm 041 - Disclosure - Note 10 - Income Taxes (Details Textual) Sheet http://www.veracyte.com/20200930/role/statement-note-10-income-taxes-details-textual Note 10 - Income Taxes (Details Textual) Details http://www.veracyte.com/20200930/role/statement-note-10-income-taxes 42 false false All Reports Book All Reports vcyt20200930_10q.htm ex_197467.htm ex_197468.htm ex_197469.htm ex_197470.htm ex_207290.htm ex_207336.htm vcyt-20200930.xsd vcyt-20200930_cal.xml vcyt-20200930_def.xml vcyt-20200930_lab.xml vcyt-20200930_pre.xml http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true